Characteristics of nifedipine loaded PLGA wafer

Polymer (Korea)

Volumn 25, Issue 6, 2001, Pages 884-892

  Seo, Sun Ah ^a   Choi, Hak Soo ^a   Lee, Dong Hun ^a   Khang, Gilson ^a   Lee, Hai Bang ^b  

^a Chonbuk National University   (South Korea)

^b Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Biodegradable wafer; Hypertension; Nifedipine; Poly(L lactide co glycolide)

Indexed keywords

EID: 0038100834     PISSN: 0379153X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. S. Kroeber, C. Schomerus, and H.-W. Korf, Brain Research, 744, 68 (1997).
2. N. Hayase, Y. I. Itagaki, S. Ogawa, S. Akutsu, S. Inagaki, and Y. Abiko, J. Pharm. Sci., 83, 532 (1994).
3. J. S. Grundy, R. Kherani, and R. T. Foster, J. Pharm. Biomed. Anal., 12, 1529 (1994).
4. S. B. Trippel, J. Bone Joint Surg., 68A, 1297 (1986).
5. K. Tateshita, S. Sugawara, T. Imai, and M. Otagiri, Bio. Pharm. Bull., 16, 420 (1993).
6. T. Chandy and C. P. Sharma, Biomaterials, 13, 949 (1992).
7. P. Sansdrap and A. J. Moes, Int. J. Pharm., 98, 157 (1993).
8. A. Bakai, Y. V. Pathak, and S. Benita, Drug Dev. Ind. Pharm., 16, 2057 (1990).
9. W. H. Chuo, T. R. Tsai, S. H. Hsu, and T. M. Cham, Int. J. Pharm., 144, 241 (1996).
10. J. C. Cho, G. Khang, J. M. Rhee, Y. S. Kim, J. S. Lee, and H. B. Lee, Korea Polymer J., 7, 79 (1999).
11. G. Khang, J. C. Cho, J. W. Lee, J. M. Rhee, and H. B. Lee, Bio-Med. Mater. Eng., 9, 45 (1999).
12. G. Khang, J. C. Cho, J. M. Rhee, J. S. Lee, and H. B. Lee, Polymer Preprints, 40, 288 (1999).
13. H. B. Lee, G. Khang, J. C. Cho, J. M. Rhee, and J. S. Lee, "Fentanyl-loaded PLGA micros-pheres for local anesthesia", in "Controlled Drug Delivery; Designing Technologies for the Future", eds. by K. Park and R. J. Mrnsyin p. 385, ACS Symp. Series 752, ACS, Washington D.C., 2000.
14. M-C, Bissery, F. Valeriote, and C. Thies, "In vitro and in vivo Evaluation of BCNU-loaded Microspheres Prepared from Poly((D-L)-lactide) and Poly (β- hydroxybutyrate)," in "Microspheres and Drug Therapy; Pharmaceutical Immunological and Medical Aspects", eds. by S. S. Davis, L. Illum, J. G. McVie, and T. linson, p. 217, Elsevier Sci., New York, 1984.
15. K. Juni and M. Nakano, CRC Crit. Rev. Therap. Drug Carrier Syst., 3, 209 (1987).
16. T. W. Atkins and S. J. Peacock, J. Microencapsulation, 13, 709 (1996).
17. J. Mauduit, N. Buhk, and M. Vert, J. Control. Rel., 23, 221 (1993).
18. G. Khang, H. S. Choi, J. M. Rhee, S. C. Yoon, J. C. Cho, and H. B. Lee, Korea Polymer J., 8(6), 253 (2000).
19. H. S. Choi, S. W. Kim, D. I. Yun, G. Khang, J. M. Rhee, and H. B. Lee, Polymer(Korea), 25, 334 (2001).
20. P. Sansolrap and A. J. Moes, J. Control. Rel., 43 (1997).
21. S. Akhtar and C. W. Pouton, Drug News Perspectives, 2, 89 (1989).
22. R. S. Chaudhary, S. S. Gangwal, V. K. Gupta, Y. N. Shah, K. C. Jindal, and S. Khanna, Drug Dev. Ind. Pharm., 23, 1267 (1994).
23. J. S. Grundy, K. E. Anderson, J. A. Rogers, and R. T. Foster, J. Control. Release, 48, 1 (1997).
24. N. Mark, The United States Pharmacopeia (USP), 23, United States Pharmacopeial Convention, INC, Rockville, MD, 1995.
25. H. S. Abou-Auda, T. A. Najjar, K. I. Al-Khamis, B. M. Al-Hadiya, N. M. Ghilzai, and N. F. Al-Fawzan. J. Pharm. Biom. Anal, 22, 241 (2000).
26. L. Maggi, M. L. Torre, P. Giunche, and U. Conte, Int. J. Pharm., 135, 73 (1996).
27. A. G. Hausberger and P. P. DeLuca, J. Pharm. Biomed. Anal, 13, 747 (1995).
28. S. Akhtar, C. W. Pouton, L. J. Notarianni, and P. L. Gould, J. Pharm. Pharmacol., 40, 118 (1988).
29. A. Gopferich, "Mechanisms of Polymer Degradation and Elimination," in "Handbook of Biodegradable Polymers", eds. by A. J. Domb, J. Kost, and D. M. Wisemanin, p. 458, London, 2000.
30. H. Okada and H. Toguchi, CRC Crit. Rev. Therap. Drug Carrier Syst., 12, 1 (1995).